A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: HR-positive, HER2-negative Advanced Breast Cancer
Interventions: DRUG: TQB3616 capsules|DRUG: Fulvestrant injection
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.